88 related articles for article (PubMed ID: 8971164)
21. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
[TBL] [Abstract][Full Text] [Related]
22. Cyclosporine directly causes oxidative stress and promotes Epstein-Barr virus transformation of human B cells.
Chen C; Johnston TD; Reddy KS; Merrick JC; Mastrangelo M; Ranjan D
J Surg Res; 2001 Oct; 100(2):166-70. PubMed ID: 11592787
[TBL] [Abstract][Full Text] [Related]
23. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
[TBL] [Abstract][Full Text] [Related]
25. EBV-induced expression and HLA-DR-restricted presentation by human B cells of alpha B-crystallin, a candidate autoantigen in multiple sclerosis.
van Sechel AC; Bajramovic JJ; van Stipdonk MJ; Persoon-Deen C; Geutskens SB; van Noort JM
J Immunol; 1999 Jan; 162(1):129-35. PubMed ID: 9886378
[TBL] [Abstract][Full Text] [Related]
26. T and IgA B lymphocytes of the pharyngeal and palatine tonsils: differential expression of adhesion molecules and chemokines.
Bourges D; Wang CH; Chevaleyre C; Salmon H
Scand J Immunol; 2004 Oct; 60(4):338-50. PubMed ID: 15379858
[TBL] [Abstract][Full Text] [Related]
27. Characteristics of Epstein-Barr virus-carrying lymphoblastoid cells derived from human tonsil: EBV production and autoantibody response.
Takimoto T; Tanaka S; Ishikawa S; Masuda K; Umeda R
ORL J Otorhinolaryngol Relat Spec; 1989; 51(5):257-61. PubMed ID: 2554232
[TBL] [Abstract][Full Text] [Related]
28. Search for infectious Epstein-Barr virus-releasing cell lines, with particular reference to a new producer line, NHAd-60.
Sakamoto K
Gan; 1977 Apr; 68(2):145-50. PubMed ID: 196968
[TBL] [Abstract][Full Text] [Related]
29. [Infection of Epstein-Barr virus to human epithelial cells derived from primary culture of adenoid tissue].
Furukawa M; Ohoka H; Ikeda C; Nishimura T; Umeda R
Nihon Jibiinkoka Gakkai Kaiho; 1988 Jan; 91(1):20-6. PubMed ID: 2838595
[No Abstract] [Full Text] [Related]
30. Proliferation and differentiation in isogenic populations of peripheral B cells activated by Epstein-Barr virus or T cell-derived mitogens.
O'Nions J; Allday MJ
J Gen Virol; 2004 Apr; 85(Pt 4):881-895. PubMed ID: 15039531
[TBL] [Abstract][Full Text] [Related]
31. [Interaction of human embryo cells derived from different tissues with lymphoblastoid cell lines].
Liu YX; Jin SH; Jin Q; Zhao XH; Wang MF; Dong WP
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):336-8. PubMed ID: 3032543
[TBL] [Abstract][Full Text] [Related]
32. Functionally active Epstein-Barr virus-transformed follicular dendritic cell-like cell lines.
Lindhout E; Lakeman A; Mevissen ML; de Groot C
J Exp Med; 1994 Apr; 179(4):1173-84. PubMed ID: 8145036
[TBL] [Abstract][Full Text] [Related]
33. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells.
Hsiao FC; Lin M; Tai A; Chen G; Huber BT
J Immunol; 2006 Aug; 177(4):2056-60. PubMed ID: 16887963
[TBL] [Abstract][Full Text] [Related]
34. Production of diphtheria antitoxin antibody in Epstein-Barr virus-induced lymphoblastoid cell lines.
Tsuchiya S; Yokoyama S; Yoshie O; Ono Y
J Immunol; 1980 Apr; 124(4):1970-6. PubMed ID: 6245131
[No Abstract] [Full Text] [Related]
35. The immune response in adenoids and tonsils.
van Kempen MJ; Rijkers GT; Van Cauwenberge PB
Int Arch Allergy Immunol; 2000 May; 122(1):8-19. PubMed ID: 10859465
[TBL] [Abstract][Full Text] [Related]
36. [Biochemical-immunological comparison of the lymphoid cells of tonsils and adenoids (author's transl)].
Siegel G
Laryngol Rhinol Otol (Stuttg); 1978 Jul; 57(7):650-3. PubMed ID: 210342
[TBL] [Abstract][Full Text] [Related]
37. Herpesvirus infections in adenoids in patients with chronic adenotonsillar disease.
Ivaska LE; Silvoniemi A; Mikola E; Puhakka T; Waris M; Vuorinen T; Jartti T
J Med Virol; 2022 Sep; 94(9):4470-4477. PubMed ID: 35488185
[TBL] [Abstract][Full Text] [Related]
38. Spontaneous lymphoblastoid transformation of cells obtained from human tonsils.
Takimoto T; Tanaka S; Masuda K; Umeda R
ORL J Otorhinolaryngol Relat Spec; 1989; 51(2):77-82. PubMed ID: 2540474
[TBL] [Abstract][Full Text] [Related]
39. EBV persistence involves strict selection of latently infected B cells.
Joseph AM; Babcock GJ; Thorley-Lawson DA
J Immunol; 2000 Sep; 165(6):2975-81. PubMed ID: 10975805
[TBL] [Abstract][Full Text] [Related]
40. Human interferon production in tonsil and adenoid tissue cultures.
Richtsmeier WJ
Am J Otolaryngol; 1983; 4(5):325-33. PubMed ID: 6314833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
